Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AETHLON MEDICAL INCAEMD · Entity 8580 | Chief Medical Officer | February 10, 2022 | February 11, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AETHLON MEDICAL INC
Report date February 10, 2022 · Filed February 11, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.41 · Expires 2032-02-09 | Direct | 100,200 |
Reported balance
After 2022-02-10 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2022-02-10 · Grant · Acquired 100,200 · Balance 100,200 F1: 25% of the shares subject to the stock option shall vest and become exercisable on February 10, 2023, and the remaining shares shall vest and become exercisable in 36 equal monthly installments thereafter. |
Filing footnotes · ownership attribution and instrument terms
F1: 25% of the shares subject to the stock option shall vest and become exercisable on February 10, 2023, and the remaining shares shall vest and become exercisable in 36 equal monthly installments thereafter.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 10, 2022 Filed Feb 11, 2022 18:55 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | GrantEmployee Stock Option (Right to Buy) · Derivative | 100,200 | $0.00 Strike: $1.41 | $0.00 |
DisclosureSEC source: 0001209191-22-008772 · doc4.xml · derivative · entry 1 LAROSA STEVEN P · CIK 0001839524 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,200 Underlying: Common Stock · 100,200 shares Expires 2032-02-09 F1 · derivative.exercise_date: 25% of the shares subject to the stock option shall vest and become exercisable on February 10, 2023, and the remaining shares shall vest and become exercisable in 36 equal monthly installments thereafter. Read SEC document |
| January 04, 2021 Filed Jan 7, 2021 23:30 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | GrantEmployee Stock Option (Right to Buy) · Derivative | 120,883 | $0.00 Strike: $2.52 | $0.00 |
DisclosureSEC source: 0001209191-21-002594 · doc4.xml · derivative · entry 1 LAROSA STEVEN P · CIK 0001839524 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,883 Underlying: Common Stock · 120,883 shares Expires 2031-01-03 F1 · derivative.exercise_date: 25% of the shares subject to the stock option shall vest and become exercisable on January 4, 2022, and the remaining shares shall vest and become exercisable in 36 equal monthly installments thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.